Short answer · Medically reviewed summary · Last updated: 2026-05-08
Paroxysmal Kinesigenic Choreathetosis (PKC), also known as Paroxysmal Kinesigenic Dyskinesia (PKD), is a rare neurological movement disorder characterized by brief, sudden attacks of involuntary movements triggered by a sudden voluntary movement. These episodes typically last less than one minute and can occur multiple times throughout the day, though they do not involve a loss of consciousness. What are the symptoms and body systems affected by Paroxysmal Kinesigenic Choreathetosis? Paroxysmal Kinesigenic Choreathetosis affects the motor system, specifically the basal ganglia, which regulates movement.
Paroxysmal Kinesigenic Choreathetosis (PKC), also known as Paroxysmal Kinesigenic Dyskinesia (PKD), is a rare neurological movement disorder characterized by brief, sudden attacks of involuntary movements triggered by a sudden voluntary movement. These episodes typically last less than one minute and can occur multiple times throughout the day, though they do not involve a loss of consciousness.
Paroxysmal Kinesigenic Choreathetosis affects the motor system, specifically the basal ganglia, which regulates movement. During an episode, a person may experience involuntary jerking (chorea), twisting (athetosis), or stiffening (dystonia) of the limbs. These movements are often unilateral (affecting one side) or bilateral and are specifically precipitated by a sudden movement, such as standing up quickly or starting to run. Patients with Paroxysmal Kinesigenic Choreathetosis report that the attacks are brief, usually lasting only seconds to a minute, and patients remain fully conscious during these events.
Paroxysmal Kinesigenic Dyskinesia is a rare disorder with an estimated prevalence of 1 in 150,000. It typically presents in childhood or adolescence, usually between the ages of 5 and 15 years. While it affects both genders, it is noted to be more common in males with a ratio of approximately 3:1. Because it is a rare condition, our community at DiseaseMaps.org currently supports 7 individuals who are navigating the challenges of living with this diagnosis.
The majority of cases of Paroxysmal Kinesigenic Choreathetosis are linked to mutations in the PRRT2 gene, which is involved in synaptic transmission and neurotransmitter release. Key characteristics of the condition include:
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.